Concierge MD LA review

The compounded pricing here is ordinary and reasonable — two molecules, one figure each, both stated per month and both around the middle of the range. What surrounds it is where you should slow down. The branded line prices four different drugs from two different manufacturers at the identical figure, which is not how branded acquisition costs behave and reads more like a rate applied across a category than four prices anyone negotiated. Taken at face value it is far above what those products cost through manufacturer channels, so it is unlikely to be the route you want. One correction belongs on the record. An earlier version of this review reported that Concierge MD LA sells retatrutide — an investigational compound approved nowhere — at a monthly rate. That could not be reproduced: three of its product pages, loaded twice each, carry no mention of it and no such figure, and the only retatrutide page on its own sitemap is an article with no price attached. Writing about a compound is not selling one, and the claim came out rather than being softened.

Vs median

$30/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

Concierge MD LA does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

The compounded pricing here is ordinary and reasonable — two molecules, one figure each, both stated per month and both around the middle of the range. What surrounds it is where a reader should slow down. The branded line prices four different drugs from two different manufacturers at the identical figure, which is not how branded acquisition costs behave and reads more like a rate applied across a category than four prices anyone negotiated. Taken at face value it is far above what those products cost through manufacturer channels, so it is unlikely to be the route a reader wants. A note on what this row used to say: it previously reported that Concierge MD LA sells retatrutide, an investigational compound with no approval anywhere, at a monthly rate. That could not be reproduced. Its product pages carry semaglutide and tirzepatide only, and the single retatrutide page on its sitemap is an article with no price attached. Writing about a compound is not selling it, and the distinction matters enough that the claim came out rather than being softened.

The four branded products are each listed at the same four-figure rate, which no manufacturer channel supports.

• Four different branded drugs are all priced at the same four-figure rate.
• No dose sits behind any figure on the page.

Concierge MD LA is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Is compounded GLP-1 safe?
• Is it still legal?
• The true annual cost of a plan